Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Jaguar Health Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lineage Cell Therapeutics Inc. June 9, 202698.9%
-
Lineage Cell Therapeutics Inc. June 26, 202598.6%
-
Jaguar Health Inc. June 21, 202493.4%
-
Lineage Cell Therapeutics Inc. June 11, 202497.5%
-
Lineage Cell Therapeutics Inc. September 6, 202397.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Jaguar Health Inc. | Grant or award | +5,870 | — | — |
| Dec 29, 2023 | Lineage Cell Therapeutics Inc. | Open-market purchase | +10,000 | $1.09 | $10,900 |
| Aug 14, 2023 | Jaguar Health Inc. | Grant or award | +68,568 | — | — |
| Jul 1, 2023 | Jaguar Health Inc. | Grant or award | +1,718 | — | — |
Questions about Anula Jayasuriya
What boards is Anula Jayasuriya on?
Anula Jayasuriya sits on the boards of Jaguar Health Inc. and Lineage Cell Therapeutics Inc.
How long has Anula Jayasuriya served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.